Schito GC - Search Results

1

Efficacy of Ursolic Acid-Enriched Water-Soluble and Not Cytotoxic Nanoparticles against Enterococci.

Schito AM, Caviglia D, Piatti G, Zorzoli A, Marimpietri D, Zuccari G, Schito GC, Alfei S. Schito AM, et al. Among authors: schito gc. Pharmaceutics. 2021 Nov 21;13(11):1976. doi: 10.3390/pharmaceutics13111976. Pharmaceutics. 2021. PMID: 34834390 Free PMC article.

2

Synthesis and Antibacterial Activity of Cationic Amino Acid-Conjugated Dendrimers Loaded with a Mixture of Two Triterpenoid Acids.

Schito AM, Schito GC, Alfei S. Schito AM, et al. Among authors: schito gc. Polymers (Basel). 2021 Feb 9;13(4):521. doi: 10.3390/polym13040521. Polymers (Basel). 2021. PMID: 33572439 Free PMC article.

3

Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.

Schito AM, Schito GC. Schito AM, et al. Among authors: schito gc. J Chemother. 2004 Apr;16 Suppl 2:3-7. doi: 10.1080/1120009x.2004.11782365. J Chemother. 2004. PMID: 15255554 Review. No abstract available.

4

Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.

Roveta S, Schito AM, Marchese A, Schito GC. Roveta S, et al. Among authors: schito am, schito gc. Int J Antimicrob Agents. 2005 Nov;26(5):366-72. doi: 10.1016/j.ijantimicag.2005.07.015. Epub 2005 Oct 7. Int J Antimicrob Agents. 2005. PMID: 16216467

5

In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance.

Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM. Marchese A, et al. Among authors: schito gc, schito am. Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:53-9. doi: 10.1016/s0924-8579(03)00230-9. Int J Antimicrob Agents. 2003. PMID: 14527772

6

Antibacterial and ATP Synthesis Modulating Compounds from Salvia tingitana.

Bisio A, Schito AM, Pedrelli F, Danton O, Reinhardt JK, Poli G, Tuccinardi T, Bürgi T, De Riccardis F, Giacomini M, Calzia D, Panfoli I, Schito GC, Hamburger M, De Tommasi N. Bisio A, et al. Among authors: schito gc. J Nat Prod. 2020 Apr 24;83(4):1027-1042. doi: 10.1021/acs.jnatprod.9b01024. Epub 2020 Mar 17. J Nat Prod. 2020. PMID: 32182064 Free PMC article.

7

Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms.

Marchese A, Bozzolasco M, Gualco L, Debbia EA, Schito GC, Schito AM. Marchese A, et al. Among authors: schito gc, schito am. Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:95-100. doi: 10.1016/s0924-8579(03)00232-2. Int J Antimicrob Agents. 2003. PMID: 14527779

8

In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.

Gualco L, Schito AM, Schito GC, Marchese A. Gualco L, et al. Among authors: schito am, schito gc. Int J Antimicrob Agents. 2007 Jun;29(6):679-87. doi: 10.1016/j.ijantimicag.2007.01.009. Epub 2007 Mar 23. Int J Antimicrob Agents. 2007. PMID: 17363225

9

Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis.

Roveta S, Schito AM, Marchese A, Schito GC. Roveta S, et al. Among authors: schito am, schito gc. Int J Antimicrob Agents. 2007 Nov;30(5):415-21. doi: 10.1016/j.ijantimicag.2007.06.029. Epub 2007 Sep 4. Int J Antimicrob Agents. 2007. PMID: 17768034

10

In vitro activity of ertapenem against selected respiratory pathogens.

Marchese A, Gualco L, Schito AM, Debbia EA, Schito GC. Marchese A, et al. Among authors: schito am, schito gc. J Antimicrob Chemother. 2004 Nov;54(5):944-51. doi: 10.1093/jac/dkh445. Epub 2004 Oct 7. J Antimicrob Chemother. 2004. PMID: 15472001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page